Skip to search formSkip to main contentSkip to account menu
Classification criteria for Sjögren's syndrome: a revised version of the European criteria proposed by the American-European Consensus Group
TLDR
These classification criteria for Sjögren's syndrome have been re-examined by consensus group members, who have introduced some modifications, more clearly defined the rules for classifying patients with primary or secondary SS, and provided more precise exclusion criteria.
View on BMJ
Preliminary criteria for the classification of Sjögren's syndrome. Results of a prospective concerted action supported by the European Community.
TLDR
Using the findings of this prospective multicenter European study, general agreement can be reached on the diagnostic procedures to be used for patients with SS.
View on PubMed
Clinical manifestations and early diagnosis of Sjögren syndrome.
TLDR
Armed with the recently refined criteria for diagnosis, specialists, such as rheumatologists, primary care physicians, ophthalmologists, and dentists, who would otherwise focus only on those symptoms that encompass their areas of expertise, can get a comprehensive image of the presenting patient, leading to earlier identification and treatment of SS.
View on PubMed
Clinical evolution, and morbidity and mortality of primary Sjögren's syndrome.
View on PubMed
The European Community Study Group on diagnostic criteria for Sjögren's syndrome. Sensitivity and specificity of tests for ocular and oral involvement in Sjögren's syndrome.
TLDR
The results clearly show that ScT and RBS (for the eye evaluation), and SGS, PS, MSGB and UWSC (for salivary gland involvement) are the most reliable tests for the diagnosis of SS.
View on BMJ
EuropeanStudy Group on Classification Criteria for Sjögren's Syndrome. Classificationcriteria for Sjögren's syndrome: a revised version of the European criteriaproposed by the American-European…
Infliximab and methotrexate in the treatment of rheumatoid arthritis: a systematic review and meta-analysis of dosage regimens.
View on PubMed
Long-term risk of mortality and lymphoproliferative disease and predictive classification of primary Sjögren's syndrome.
TLDR
In patients with primary SS, 1 in 5 deaths is attributable to lymphoma and the presence of palpable purpura and low C4 levels at the first visit adequately distinguishes high-risk patients (type I primary SS) from patients with an uncomplicated disease course (type II [low-risk] primary SS).
View on PubMed
The risk of lymphoma development in autoimmune diseases: a meta-analysis.
TLDR
A meta-analysis of all available cohort studies linking systemic lupus erythematosus, rheumatoid arthritis, and primary Sjögren syndrome (pSS) to the risk of NHL development suggested extreme heterogeneity among the studies, and the underlying pathophysiologic mechanisms related to lymphomagenesis in pSS, SLE, and RA may present a potential risk factor for development of NHL.
View on PubMed
Assessment of the European classification criteria for Sjögren's syndrome in a series of clinically defined cases: results of a prospective multicentre study. The European Study Group on Diagnostic…
TLDR
This prospective study confirmed the high validity and reliability of the classification criteria for Sjögren's syndrome recently proposed by the European Community Study Group.
View on BMJ
...
...
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy, Terms of Service, and Dataset License